Ebola’s Mortality Rate and the Medical Reasons Why This Virus Is Difficult to Cure
Ebola Virus Disease (EVD) remains one of the most challenging medical problems in the history of modern health. Known for its sudden onset and devastating effects, Ebola is not merely a typical infection; it is a systemic assault that cripples the human body’s defenses.
The death rate or Case Fatality Rate (CFR) of Ebola is among the highest in medical science. Based on historical data from the World Health Organization (WHO), the average mortality rate sits around 50%. Yet this figure fluctuates depending on outbreak location, virus strain, and the speed of medical intervention.
In certain outbreaks in remote areas with limited access to healthcare, mortality has climbed to 90%. By comparison, this mortality rate far surpasses other infectious diseases such as COVID-19 or seasonal influenza, placing Ebola in the category of high-level pathogens (Biosafety Level 4).
Not all Ebola viruses have the same virulence. There are five Ebola virus species, with three of them having caused large outbreaks in humans:
The difficulty in curing Ebola stems from the way this virus interacts with human biology. Here are the main reasons:
Ebola is a cunning deceiver. Once it enters the body, the virus targets key immune system cells, particularly dendritic cells and macrophages. These cells should act as scouts, signaling lymphocytes (T cells and B cells) to begin antibody production. By disabling these scouts, the virus can replicate massively without detection by the body’s defence system in the early, crucial phase.
When the immune system finally recognises the virus, the response is often late and excessive. The body releases inflammatory signalling molecules (cytokines) in uncontrolled quantities. Instead of killing the virus, this ‘cytokine storm’ damages blood vessels and body tissues, causing fluid leakage and organ failure.
The Ebola virus possesses the ability to replicate at extraordinary speed. In a short time, the number of viral particles in the blood (viral load) can become very high, overwhelming vital organs such as the liver, spleen, and kidneys before drugs or the immune system can react.
Ebola causes necrosis (tissue death) in the liver. Since the liver is responsible for producing blood clotting factors, its damage triggers internal bleeding that is difficult to stop.
To date, there is no antiviral drug that can instantly shut down the Ebola virus once infection has reached advanced stages. Some major obstacles include:
Although difficult, that does not mean Ebola cannot be treated. The key to improving survival is early supportive care. Aggressive electrolyte and fluid replacement (rehydration) can help the body endure long enough for the immune system to produce antibodies to combat the virus.
Additionally, the use of monoclonal antibodies (such as Inmazeb and Ebanga) has shown highly promising results in clinical trials, significantly reducing mortality when given soon after symptoms appear.
The high mortality rate of Ebola and the difficulty of cure are due to the virus’s ability to hijack the immune system and disrupt the integrity of the human vascular system. The success in fighting Ebola outbreaks relies heavily on rapid detection and the readiness of medical infrastructure to provide antibody therapy and intensive rehydration before organ damage becomes permanent. (H-3)
A comprehensive guide to Ebola disease, transmission, high mortality, and pandemic potential according to global health experts.
Complete information on the Ebola vaccines status (Ervebo & Zabdeno) and analysis of the risk of Ebola entering Indonesia based on global health protocols.
WHO declared Ebola outbreaks in Bundibugyo in Congo and Uganda a global health emergency after claiming nearly 100 lives in May 2026.
DIREKTUR pascasarjana Universitas YARSI Tjandra Yoga Aditama assesses that the Ebola outbreak currently occurring in Africa requires strengthened international cooperation.
US President Donald Trump admitted to worrying about the Ebola outbreak in Congo after an American doctor contracted the virus. The US immediately blocked foreign travellers.